Researchers warn that the public, policy makers and even clinicians are not aware of the growing problem of liver cancer.

The majority of liver cancer cases could be prevented by reducing levels of viral hepatitis, alcohol consumption and MASLD ...

Advances such as triple agonists, gene editing, and microbiome therapy offer hope for metabolic diseases, but global access and early detection remain limited.

Without efforts to address some causes, including alcohol use and metabolic issues, the researchers warn that cases could ...

MASLD is highly prevalent among individuals with chronic hepatitis B and increases the risk for liver fibrosis.

Liver cancer is still relatively rare in the United States, representing 2.1% of all new cancer diagnoses in 2025. The report ...

Sixty percent of liver cancers are preventable by controlling risk factors including hepatitis B and C, alcohol consumption, ...

Poor dietary habits and obesity are key contributors to non-alcoholic fatty liver disease (NAFLD).leading to inflammation and ...

At least 60% of liver cancers globally are preventable through risk-factor reduction, including obesity-linked metabolic ...

More than 500,000 annual liver cancer diagnoses could be prevented with global interventions aimed at reducing viral hepatitis B and C, alcohol consumption and a disease strongly associated with ...

The majority of liver cancer cases could be prevented by reducing levels of viral hepatitis, alcohol consumption and MASLD ...

Gallstone disease is linked to metabolic disorders, such as obesity, diabetes, and metabolic dysfunction-associated steatotic liver disease.